TP53 and ductal breast carcinoma in situ: However, there were also late clonal pure DCIS recurrences, (P003) which relapsed with pure DCIS after 8 years despite radiotherapy and endocrine therapy; both primary and recurrence shared a pathogenic TP53 driver mutation (Extended Data Fig. 3d).